Project Grant HT9425261E254
Award Date 9/30/26
Completion Date 9/29/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- The Defense Health Agency awarded a $1,316,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "ADVANCING WRN AS A PROMISING THERAPEUTIC TARGET FOR MSI-H CANCERS" to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $1.6M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research investigating the role of Streptococcus in esophageal neoplasia, with research activities conducted at the institution's facilities in New York, NY. This three-year funded initiative falls within...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York a $1,099,932 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2030. The grant funds research titled "Optimization of Targeted Drug Delivery and Radiosensitizing Strategies for Pediatric Diffuse Midline Glioma," to be conducted at Columbia University's Health Sciences Division in New...
- The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $1.645 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2028. The award funds research investigating bone fracture-induced joint bleeding and its role in posttraumatic osteoarthritis development. This research aligns with the DHA's mission...
- The Department of the Army Medical Command awarded a $162,000 project grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program. The grant supports the development of amyloid fibril-specific chimeric antigen receptor macrophages (CAR-M)-based immunotherapy for amyloid clearance in light chain amyloidosis from August 1, 2021 through July 31, 2023. The Military Medical Research and Development program (CFDA 12.420) aims to conduct...
- Federal Grant Award Summary New York University School of Medicine received a $750,962 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 15, 2026 through June 14, 2029. The award supports a three-year research initiative titled "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," which investigates the mechanisms underlying immunotherapy benefit and...
- Federal Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $822,499 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with completion targeted for August 14, 2028. The award supports research investigating the role of methionine oxidation in cancer-associated cachexia, a condition characterized by progressive muscle and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Columbia University's Health Sciences Division a $750,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. The award supports research to identify novel therapeutic targets that overcome treatment resistance in triple-negative breast cancer (TNBC), a particularly aggressive form of cancer affecting military-connected populations and the broader...